| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |